The weight loss achieved by CagriSema (-20.4% at 68 weeks) is comparable to that reported with the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (-20.9% with the 15-mg dose at 72 weeks in SURMOUNT-1) [14]
Our programs are tailored to fit your unique needs, ensuring you get the most effective support for your weight loss journey
Lawsuits may allege that companies were negligent in their testing processes or ignored early warning signs of potential hazards
This slow ramp-up gives your body time to adjust and helps minimize common side effects like nausea, constipation, and diarrhea
Once the pharmacy has received your prescription, the current month payment is non-refundable but the cancellation applies to the next billing cycle
Secure Simple Accessible anytime from any device Access My Patient Portal Availability updates & treatment insights Subscribe for availability updates, announcements, and treatment insights